Brief: Invion Announces Preclinical Research Collaboration With Percheron Therapeutics
Mon 23:35
BRIEF-Invion Announces Preclinical Research Collaboration With Percheron Therapeutics Oct 20 (Reuters) - Invion Ltd IVX.AX:
ANNOUNCES PRECLINICAL RESEARCH COLLABORATION WITH PERCHERON THERAPEUTICS
COLLABORATION TO EVALUATE HMBD-002 WITH INVION'S PHOTOSOFT PLATFORM TECHNOLOGY
Further company coverage: IVX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Percheron Therapeutics
See all newsBrief: Invion Announces Preclinical Research Collaboration With Percheron Therapeutics
Brief: Percheron Therapeutics Receives Firm Commitments For A$2.3 Million Institutional Placement
Brief: Percheron Therapeutics Appoints Ambrosini as Interim Board Member During CEO Transition Period
Brief: Percheron Therapeutics Says Vanderbilt Health To Conduct Clinical Trial Of Hmbd-002 In Acute Myeloid Leukaemia
Brief: Percheron Therapeutics Says James Garner To Step Down As CEO And Managing Director